Hidradenitis Suppurativa (HS) Completed Phase 2 Trials for Adalimumab (DB00051)

Also known as: Hidradenitis Suppurativa / Hidradenitis / Sweat gland inflammation / Acne inversa

IndicationStatusPhase
DBCOND0054533 (Hidradenitis Suppurativa (HS))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03248531A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa.Treatment
NCT00827996To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Hidradenitis SuppurativaTreatment
NCT00918255Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis SuppurativaTreatment